Quantum Financial Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
Quantum Financial Advisors's BMY Position: Q2 2026 in Review
Quantum Financial Advisors increased its Bristol-Myers Squibb (BMY) stake by 0.04% in Q2 2026, buying an estimated $115 and bringing the position to 4,902 shares worth $282K. The position accounts for 0.03% of the portfolio, ranked #185.
Quantum Financial Advisors first reported a position in BMY in Q4 2022 and has held it in 6 quarters since. The position peaked at $297K in Q1 2026. 878 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Quantum Financial Advisors held 4,902 shares of Bristol-Myers Squibb worth $282K as of Q2 2026.
- Quantum Financial Advisors bought 2 Bristol-Myers Squibb shares in Q2 2026, an estimated $115.
- Bristol-Myers Squibb made up 0.03% of Quantum Financial Advisors's portfolio in Q2 2026, its #185 holding.
- Quantum Financial Advisors first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 6 quarters since.
- Quantum Financial Advisors's Bristol-Myers Squibb position peaked at $297K in Q1 2026.
- 878 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Quantum Financial Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.